AC Immune SA — Cash Flow (NASDAQ:ACIU) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities ————— — Cash from investing activities ————— — Cash from financing activities ————— — Free cash flow ————— —

Haberler

AC Immune beyin geçirgen NLRP3 inhibitörü için faz 1 denemesine başladı

AC Immune begins phase 1 trial of brain-penetrant NLRP3 inhibitor

2026 Market Outlook: Focus On Pharma For Consistent Returns, Potential Skyrocketing Shares

AC Immune: Maintaining 'Buy' Rating On Next Steps For ACI-7104.056 Development In PD

Tesla and Rivian among market cap stock movers on Friday

AC Immune Trial Shows Early Signs Immunotherapy May Slow Parkinson's - AC Immune (NASDAQ:ACIU)

AC Immune hisseleri olumlu Parkinson hastalığı denemesi verileriyle yükseldi

AC Immune stock rises after positive Parkinson’s disease trial data

AC Immune’un Parkinson tedavisi hastalığın ilerlemesini yavaşlatmada umut veriyor

AC Immune’s Parkinson’s treatment shows promise in slowing disease

AC Immune (ACIU) Reports Q3 Loss, Lags Revenue Estimates

Alector (ALEC) May Report Negative Earnings: Know the Trend Ahead of Q3 Release